Atrium Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Atrium Therapeutics, Inc. (RNA) reported Basic Shares Outstanding (Weighted Average) of 17.11 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- Atrium Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 17.11M shares, a 0.00% change year-over-year.
- Atrium Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 17.11M shares, a 0.00% change year-over-year.
- Atrium Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 17.11M shares.
- Atrium Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 17.11M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month |
|---|---|---|
| 2026-06-30 | 17.11M shares 10-Q · filed 2026-08-13 | 17.11M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 17.11M shares 10-Q · filed 2026-05-14 | |
| 2025-06-30 | 17.11M shares 10-Q · filed 2026-08-13 | 17.11M shares 10-Q · filed 2026-08-13 |
| 2025-03-31 | 17.11M shares 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |